Lumos Pharma | NLNK - Capitalisation Boursière



Capitalisation Boursière Changement Date
Agenus USD 107M 16M 2025-12
Alterity Therapeutics Limited AUD 40M 16M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Celldex Therapeutics USD 2.17B 361M 2026-05
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Incyte USD 21.73B 3B 2026-05
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Pfizer USD 149.77B 4.04B 2026-05
Prothena USD 514M 11M 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12